Metastatic thyroid cancer is an aggressive form of cancer that has limited treatment options. The University of Alabama at ...
IGTP-led study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer
Researchers from the Endocrine Tumours group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university hospitals, have conducted the first comprehensive study of ...
Real-world treatment outcomes and clinicopathologic determinants of response for patients with advanced thyroid cancer treated with first-line lenvatinib. This is an ASCO Meeting Abstract from the ...
The efficacy and safety of anti–PD-1 antibody toripalimab combined with surufatinib in neoadjuvant treatment of locally advanced thyroid cancer: A phase II study. This is an ASCO Meeting Abstract from ...
Recurrent IRTC invading the upper aerodigestive tract remains a formidable clinical challenge. Management typically involves tracheal resection or laryngectomy, often with sacrifice of the recurrent ...
Outcome and therapy prediction using MAP score. Summary diagram showing the potential role of MAP score for risk stratifying thyroid tumors. Credit: Cell Genomics (2023). DOI: ...
European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and ...
Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results